Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Interventional Potential of Panax Genus Chinese Medicinals in Atherosclerosis Progression.

Created on 10 Jul 2026

Authors

Wenjing Li, Haiyan Li, Ronghua Zhao, Liangliang Fan, Lijia Yin, Fusong Dong, Xuxia Jia, Song Yang, Xueyuan Bai, Daqing Zhao, Jiawen Wang

Published in

Phytotherapy research : PTR. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

Atherosclerosis and its complications significantly affect human health globally. The etiology of atherosclerosis is multifaceted, with current research focusing on abnormalities in lipid metabolism, immune cell activation, inflammation, and epithelial damage. Currently, highly effective preventive and therapeutic strategies for atherosclerosis remain lacking. Recent reports have indicated the anti-atherosclerotic effects of medicinal herbs from the Araliaceae family, including Panax ginseng C. A. Mey., Panax notoginseng, Panax quinquefolius L., and Panax japonicus. The pharmacological effects of these herbs on atherosclerosis include lipid metabolism, immune cell activation, inflammation, oxidative stress, endothelial function, cell proliferation and migration, angiogenesis, apoptosis, autophagy, and gut microbiota homeostasis. This review aims to comprehensively elucidate, summarize, and update the protective effects and underlying mechanisms of Araliaceae herbs against atherosclerosis.

PMID:
42425924
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement